Global Metoprolol Succinate Market Size, Share and Trends Analysis Report, by Type (25mg, 50mg, 100mg, and 200mg Tablets), By Application (Hypertension, Angina, Others),Forecast (2022-2028)

The global metoprolol succinate market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Metoprolol succinate is used alone or in combination with other medications to treat high blood pressure, and it is also used to prevent angina (chest pain) and to improve survival after a heart attack. The increase in the prevalence of angina disease has created a demand for the development of new drugs for its treatment which in turn drives the global metoprolol succinate market growth.

Moreover, the market growth is driven by the strong focus of the pharmaceutical companies and research organizations on the R&D of drugs for angina disease creating a strong beta-blocker for effective therapy and the beta-blockers it has been shown to reduce heart rate, blood pressure, and shortness of breath, leading to a decrease in myocardial oxygen demand and a decrease in angina symptoms.

Some major players in the market include Merck & Co., Inc., GlaxoSmithKline plc, Sanofi SA, and Pfizer Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the global market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Merck & Co., Inc., GlaxoSmithKline plc, Sanofi SA, and Pfizer Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Metoprolol Succinate Market Report by Segment

By Type

• 25mg Tablet
• 50mg, Tablet
• 100mg, Tablet
• 200mgTablet

By  Application

• Hypertension
• Angina
• Others

Global Metoprolol Succinate Market Report by Region

North America

• US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa